The global geothermal heat pumps market players are struggling to achieve a steady and noticeable position in the market through product improvement while the level of rivalry amongst them is extreme. The global geothermal heat pumps mar…
BMI View: The combined value of Saudi Arabia's pharmaceutical and healthcare markets is the largest in
the Middle East and Africa region. The Kingdom's National Transformation Program, a key part of Vision
2030, reinstates the government's commitment to improving healthcare provision in the country.
Nonetheless, the rising burden of non-communicable diseases will place greater pressure on the country's
health services, while opportunities for multinational pharmaceutical companies will develop in line with
this. As such, we expect the private sector to play a pivotal role in healthcare expansion in Saudi Arabia
over the long term, principally through private health insurance schemes.
Headline Expenditure Projections
? Pharmaceuticals: SAR31.75bn (USD8.46bn) in 2015 to SAR35.14bn (USD9.37bn) in 2016; +10.7% in
both local currency and US dollar terms. Forecast in line with Q316.
? Healthcare: SAR142.86bn (USD38.10bn) in 2015 to SAR153.50bn (USD40.91bn) in 2016; +7.4% in
local currency terms and US dollar terms. Forecast in line with Q316.